Skip to main content

Animations

MJFF Publications

1741 - 1750 of 9131 Results
Title
Year
  • Year
  • 2021
  • 2017
  • 2012
  • 2025
  • 2019
  • 2022
  • 2021
  • 2017
  • 2025
  • 2026
  • Summary Details
    OPEN
    Title: Measuring Structural Racism: A Guide for Epidemiologists and Other Health Researchers
    Journal Name: American Journal of Epidemiology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/aje/kwab239
    Citation Count: 399
  • MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP
    2017
    Summary Details
    RESTRICTED
    Title: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020
    Citation Count: 55
  • Summary Details
    OPEN
    Title: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244
    Citation Count: 335
  • Summary Details
    OPEN
    Title: Deep learning-derived arterial input function for dynamic brain PET
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2025.121609
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease
    Journal Name: Current Opinion in Physiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future Applications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13503
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Prevalence and Risk Factors for Double Vision in Parkinson Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13220
    Citation Count: 12
  • Summary Details
    OPEN
    Title: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.13937
    Citation Count: 24
  • Carrying on a Father's Legacy
    2025
    Summary Details
    RESTRICTED
    Title: Carrying on a Father's Legacy
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0001125860.72537.e7
    Citation Count: 0
  • Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative
    2026
    Summary Details
    RESTRICTED
    Title: Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.78220
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.